Objective:
To evaluate the advancements and benefits of the Bausch + Lomb TENEO Excimer Laser Platform in LASIK procedures.
Key Findings:
- Surgeons achieved a manifest refractive spherical equivalent of -0.04 D at 9 months for treated eyes.
- Patients experienced fewer visual disturbances like starbursts and halos compared to glasses or contacts.
- Improved visual outcomes and patient satisfaction reported in clinical trials and real-world applications.
Interpretation:
The TENEO platform demonstrates significant advancements in LASIK technology, leading to better patient outcomes and satisfaction compared to traditional corrective lenses.
Limitations:
- The study primarily reflects outcomes from clinical trials and may not encompass all patient demographics.
- Long-term effects beyond 9 months are not fully assessed in the current findings.
Conclusion:
The Bausch + Lomb TENEO Excimer Laser Platform represents a significant step forward in LASIK technology, offering improved efficiency, safety, and patient outcomes.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.